• Sandoz has asked the European Commission to investigate Chinese imports of amoxicillin trihydrate, alleging unfair state subsidies and non-market pricing, The Financial Times reported Friday. 

• The drugmaker said Chinese imports undercut EU prices by about 47% and risked increasing European dependence on China for antibiotic ingredients.

• The complaint requested corrective measures and additional duties to prevent subsidised imports from flooding the market.

• IQVIA data cited in the complaint showed that about 80% of amoxicillin active pharmaceutical ingredients are imported from Asia.

• Sandoz said the Commission had not yet responded to the submission and requested priority review despite a full anti-dumping investigation potentially taking a year.

• China’s foreign ministry previously rejected claims of overcapacity and said protectionism would not improve competitiveness.

[Financial Times]